The final agenda for IBC’s 3rd Annual Cell Therapy Bioprocessing Conference is now available. This year’s program provides a balance of product development strategies, process development and optimization methodologies, innovation case studies, product characterization, and bioprocessing/scale-up discussions with more contextual topics like industry overviews, CoGS cost modeling, and reimbursement.Achieve commercial success with 20 case studies and new data presentations to help you:
- - Scale Immunotherapies Using High- Throughput Technologies Throughput Technologies
- - Streamline Manufacturing with Risk-Based, Unit Operation Approaches
- - Quantify the Investment of Your Cell Therapies Using Cost of Goods Modeling
- - Minimize Variation through Systematic Approaches to Process Design and Optimization
- - Enhance Quality and Enable Process Changes with New Potency Evaluation Strategies
- - Ensure Successful Scale Up and Validation by Establishing Process Consistency
- - Reduce Risk in Cell Therapy Applications by Developing Serum-Free Reagents
Want to find out more about these case studies, the keynotes and the rest of the agenda?
The Cell Therapy Bioprocessing Event will take place October 21-22 in Bethesda, Maryalnd. As a reader of this blog, when you register to join us and mention code B13188JP20 and you’ll save 20% off the standard rate. Have any questions or want to get involved in this year’s event? Feel free to email Jennifer Pereira.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment